Results 211 to 220 of about 1,410,232 (284)

Encapsulated Leptin‐Producing Cells Facilitate Entrainment of Circadian Rhythms in Rodents and Nonhuman Primates

open access: yesAdvanced Science, Volume 13, Issue 61, 3 November 2026.
A clinically translatable cell line can be engineered to produce leptin, encapsulated in biomaterial and safely implanted to produce and deliver the metabolic regulating protein within the body. Implantation of these encapsulated cells decreases the time it takes for mice and non‐human primates to adjust to circadian disruptions similar to those ...
Samantha T. Fleury   +18 more
wiley   +1 more source

Reversal of neuronal tau pathology via adiponectin receptor activation. [PDF]

open access: yesCommun Biol
McGregor ER   +6 more
europepmc   +1 more source

Identifying Systemic Lupus Erythematosus From Serum Proteomic Profiles Using Machine Learning and Genetic Risk Stratification

open access: yesArthritis &Rheumatology, Volume 78, Issue 11, Page 2280-2291, November 2026.
Objective Proteome‐wide risk models for lupus remain underexplored. We developed classification models to identify lupus from serum proteomic profiles. Methods Patients with lupus and individuals with other autoimmune diseases in the UK Biobank were included.
Mehmet Hocaoǧlu   +2 more
wiley   +1 more source

Adiponectin-receptor agonism prevents right ventricular tissue pathology in a mouse model of Duchenne muscular dystrophy. [PDF]

open access: yesMol Metab
Gandhi S   +16 more
europepmc   +1 more source

New therapeutic options for metabolic‐associated steatotic liver disease

open access: yesBritish Journal of Clinical Pharmacology, Volume 92, Issue 11, Page 3770-3777, November 2026.
An increasing number of patients are being diagnosed with metabolic dysfunction‐associated steatotic liver disease (MASLD). MASLD results from disturbances in hepatic lipid metabolism and is associated with an increased risk of cirrhosis and hepatocellular carcinoma and significant extrahepatic morbidity, including cardiovascular disease and ...
Tessa Straatmijer, Midas Mulder
wiley   +1 more source

Integrin Trafficking, Fibronectin Architecture, and Glomerular Injury upon Adiponectin Receptor 1 Depletion. [PDF]

open access: yesJ Am Soc Nephrol
Lindfors S   +17 more
europepmc   +1 more source

Curcumin Intervention in Diabetic Neuropathy: Molecular Mechanisms and Preclinical Insights

open access: yesChemistry &Biodiversity, Volume 23, Issue 11, November 2026.
This review highlights curcumin's neuroprotective potential, showing how it mitigates oxidative stress and inflammation by modulating Nrf2, MAPK, and NF‐κB signaling. Preclinical data shows it stabilizes glucose metabolism and reduces nerve degradation.
Sanket Sharma   +5 more
wiley   +1 more source

Comparison of Serum Uric Acid and Serum Uric Acid‐to‐Creatinine Ratio as Indicators of Metabolic Syndrome: A Cross‐Sectional Study in China

open access: yesEndocrinology, Diabetes &Metabolism, Volume 9, Issue 6, November 2026.
Serum uric acid and its ratio to creatinine are both valuable predictors for the early prevention, diagnosis and treatment of metabolic syndrome in routine clinical practice. ABSTRACT Objective This study aimed to systematically compare the roles of both serum uric acid (SUA) and Serum uric acid to creatine ratio (SUACr) as indicators of metabolic ...
Qiang Wang   +7 more
wiley   +1 more source

Comparative Efficacy and Safety of Saroglitazar and Dapagliflozin on Hepatic Steatosis and Glycemic Control in Patients With Metabolic Dysfunction‐Associated Steatotic Liver Disease: A 25‐Week Prospective Multicenter Comparative Cohort Study

open access: yesEndocrinology, Diabetes &Metabolism, Volume 9, Issue 6, November 2026.
In this 25‐week, non‐randomized comparative cohort study of 54 adults with MASLD and type 2 diabetes, saroglitazar and dapagliflozin both reduced hepatic steatosis, with no significant between‐group difference in steatosis or liver stiffness. Saroglitazar achieved a significantly greater HbA1c reduction, and no treatment‐emergent adverse events ...
Mukulesh Gupta   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy